<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">ojrdrt</journal-id><journal-title-group><journal-title xml:lang="ru">Онкологический журнал: лучевая диагностика, лучевая терапия</journal-title><trans-title-group xml:lang="en"><trans-title>Journal of oncology: diagnostic radiology and radiotherapy</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2587-7593</issn><issn pub-type="epub">2713-167X</issn><publisher><publisher-name>НЕКОММЕРЧЕСКОЕ ПАРТНЕРСТВО «ОБЩЕСТВО ИНТЕРВЕНЦИОННЫХ ОНКОРАДИОЛОГОВ»</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.37174/2587-7593-2025-8-1-57-64</article-id><article-id custom-type="elpub" pub-id-type="custom">ojrdrt-419</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ЛУЧЕВАЯ ДИАГНОСТИКА</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>DIAGNOSTIC RADIOLOGY</subject></subj-group></article-categories><title-group><article-title>Подбор оптимальных импульсных последовательностей и фаз контрастирования МРТ-исследования для радиомического анализа в диагностике раннего гепатоцеллюлярного рака</article-title><trans-title-group xml:lang="en"><trans-title>Selection of Optimal Pulse Sequences and Enhancement Phases of MRI Study for Radiomics Analysis in the Diagnosis of Early Hepatocellular Carcinoma</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9692-116X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Молостова</surname><given-names>Ю. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Molostova</surname><given-names>Iu. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Молостова Юлия Викторовна</p><p>+7916091148</p><p>115478, Москва, Каширское шоссе, 24</p></bio><bio xml:lang="en"><p>Iuliia V. Molostova</p><p>24 Kashirskoye Shosse, Moscow, 115478</p></bio><email xlink:type="simple">molostovajulia@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1779-003X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Медведева</surname><given-names>Б. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Medvedeva</surname><given-names>B. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>115478, Москва, Каширское шоссе, 24</p></bio><bio xml:lang="en"><p>Bela M. Medvedeva</p><p>24 Kashirskoye Shosse, Moscow, 115478</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0008-3486-302X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Геворкян</surname><given-names>Т. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Gevorkyan</surname><given-names>T. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>115478, Москва, Каширское шоссе, 24</p></bio><bio xml:lang="en"><p>Tigran G. Gevorkyan</p><p>24 Kashirskoye Shosse, Moscow, 115478</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7070-3391</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кондратьев</surname><given-names>Е. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Kondratyev</surname><given-names>E. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>115093, Москва, ул. Большая Серпуховская, 27</p></bio><bio xml:lang="en"><p>Evgeny. V. Kondratyev</p><p>27 Bolshaya Serpukhovskaya Moscow, 115093</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0005-9267-8584</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Усталов</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Ustalov</surname><given-names>A. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>115093, Москва, ул. Большая Серпуховская, 27</p></bio><bio xml:lang="en"><p>Andrey A. Ustalov</p><p>27 Bolshaya Serpukhovskaya Moscow, 115093</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6362-7914</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Новрузбеков</surname><given-names>М. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Novruzbekov</surname><given-names>M. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>129090, Москва, Большая Сухаревская площадь, 3</p></bio><bio xml:lang="en"><p>Murad S. Novruzbekov</p><p>3 Bolshaya Suharevskaya ploshad, Moscow, 129090</p></bio><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0691-5581</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Олисов</surname><given-names>О. Д.</given-names></name><name name-style="western" xml:lang="en"><surname>Olisov</surname><given-names>O. D.</given-names></name></name-alternatives><bio xml:lang="ru"><p>129090, Москва, Большая Сухаревская площадь, 3</p></bio><bio xml:lang="en"><p>Oleg D. Olisov</p><p>3 Bolshaya Suharevskaya ploshad, Moscow, 129090</p></bio><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0003-9361-8538</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Тарнопольский</surname><given-names>В. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Tarnopolsky</surname><given-names>V. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>117152, Москва, Загородное шоссе, 18А, с. 7</p></bio><bio xml:lang="en"><p>Vitaly M. Tarnopolsky</p><p>18A building 7 Zagorodnoe shosse, Moscow, 117152</p></bio><xref ref-type="aff" rid="aff-4"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Национальный медицинский исследовательский центp онкологии им. Н.Н. Блохина Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>N.N. Blokhin National Medical Research Center of Oncology</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Национальный медицинский исследовательский центp хирургии им. А.В. Вишневского Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>A.V. Vishnevsky National Medical Research Center of Surgery</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>Научно-исследовательский институт скорой помощи имени Н.В. Склифосовского Департамента здравоохранения города Москвы</institution><country>Россия</country></aff><aff xml:lang="en"><institution>The Scientific Department for Liver Transplantation, N.V. Sklifosovsky Research Institute for Emergency Medicine</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-4"><aff xml:lang="ru"><institution>Филиал Онкологический центр № 1 Городской клинической больницы имени С.С. Юдина Департамента здравоохранения города Москвы</institution><country>Россия</country></aff><aff xml:lang="en"><institution>S.S. Yudin State Clinical Hospital of the Department of Health Care of the Russian Federation</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>04</day><month>04</month><year>2025</year></pub-date><volume>8</volume><issue>1</issue><fpage>57</fpage><lpage>64</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Молостова Ю.В., Медведева Б.М., Геворкян Т.Г., Кондратьев Е.В., Усталов А.А., Новрузбеков М.С., Олисов О.Д., Тарнопольский В.М., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Молостова Ю.В., Медведева Б.М., Геворкян Т.Г., Кондратьев Е.В., Усталов А.А., Новрузбеков М.С., Олисов О.Д., Тарнопольский В.М.</copyright-holder><copyright-holder xml:lang="en">Molostova I.V., Medvedeva B.M., Gevorkyan T.G., Kondratyev E.V., Ustalov A.A., Novruzbekov M.S., Olisov O.D., Tarnopolsky V.M.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.oncoradjournal.ru/jour/article/view/419">https://www.oncoradjournal.ru/jour/article/view/419</self-uri><abstract><sec><title>Цель</title><p>Цель: Сравнение значимости различных последовательностей и фаз контрастирования МРТ-исследования для создания диагностической радиомической модели в МРТ-диагностике раннего гепатоцеллюлярного рака (ГЦР). </p></sec><sec><title>Материал и методы</title><p>Материал и методы: Ретроспективно проанализированы данные 72 пациентов с 93 узловыми образованиями, прошедших МРТ-исследование с внутривенным контрастированием гепатоспецифическим МРКС Примовист, проведена сравнительная оценка показателей четырех импульсных последовательностей и фаз контрастирования МРТ-исследования.</p></sec><sec><title>Результаты</title><p>Результаты: В результате исследования были созданы радиомические модели различных импульсных последовательностей и фаз контрастирования МРТ-исследования с высокими дискриминативными возможностями, площадь под ROC-кривой (Area Under Curve, AUC) составила от 0,58 до 0,94 в различных моделях. Наилучшие показатели продемонстрировала модель Random Forest, построенная на основе данных МРТ-исследования в гепатоспецифическую фазу (ГСФ) — AUC 0,949684, при этом точность составила 0,825000. При сочетании различных импульсных последовательностей и 4 фаз контрастирования AUC составила 0,914342, точность повысилась до 0,846591. </p></sec><sec><title>Заключение</title><p>Заключение: Наибольшие дискриминативные возможности для создания радиомических моделей диагностики ГЦР при МРТ имеют: самостоятельная гепатоспецифическая фаза внутривенного контрастирования, а также сочетание 4 МР-по следовательностей и фаз внутривенного контрастирования. </p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Purpose</title><p>Purpose: To compare the importance of different MRI sequences and enhancement phases in creation of a diagnostic radiomics model in MRI diagnostics of early hepatocellular carcinoma (HCC).</p></sec><sec><title>Material and methods</title><p>Material and methods: Data from 72 patients with 93 masses who underwent Gadoxetic acid-enhanced MRI scans was retrospectively analyzed, a comparative assessment of the indicators of four sequences and enhancement phases of MRI studies was performed.</p></sec><sec><title>Results</title><p>Results: As a result of the study, machine- learning radiomics based models on various MRI sequences and enhancement phases with high discriminatory capabilities were created. The area under the ROC curve (Area Under Curve, AUC) ranged from 0.58 to 0.94 in various models; the best results were performed in Random Forest model based on MRI-hepatobiliary enhancement phase — AUC 0.949684, the combination of different enhancement sequences — AUC 0.914342.</p></sec><sec><title>Conclusion</title><p>Conclusion: The hepatobiliary phase of MRI study independently, as well as the combination of four enhancement phases and sequences of MRI study, have the greatest discriminatory capabilities for creating machine- learning radiomics based models on enhanced MR images in diagnostics of early HCC.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>гепатоцеллюлярный рак</kwd><kwd>МРТ</kwd><kwd>радиомика</kwd><kwd>текстурный анализ</kwd><kwd>гадоксетовая кислота</kwd><kwd>фазы контрастрирования</kwd></kwd-group><kwd-group xml:lang="en"><kwd>HCC</kwd><kwd>MRI</kwd><kwd>radiomics</kwd><kwd>gadoxetic acid</kwd><kwd>enhancement phases</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Это исследование было проведено со спонсорской поддержкой Аналитического центра при Правительстве Российской Федерации (Соглашение №. 70-2024-000121 dd 29.03.2024. IGK 000000D730324P540002).</funding-statement><funding-statement xml:lang="en">This research has been financially supported by The Analytical Center for the Government of the Russian Federation (Agreement No. 70-2024-000121 dd 29.03.2024. IGK 000000D730324P540002).</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Global Burden of Disease Liver Cancer Collaboration, Akinyemiju T, Abera S, et al. The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level: Results From the Global Burden of Disease Study 2015. JAMA Oncol. 2017;3(12):1683-91. https://doi.org/10.1001/jamaoncol.2017.3055</mixed-citation><mixed-citation xml:lang="en">Global Burden of Disease Liver Cancer Collaboration, Akinyemiju T, Abera S, et al. The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level: Results From the Global Burden of Disease Study 2015. JAMA Oncol. 2017;3(12):1683-91. https://doi.org/10.1001/jamaoncol.2017.3055</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Forner A, Reig M, Bruix J. Hepatocellular carcinoma. Lancet. 2018;391(10127):1301-14. https://doi.org/10.1016/S0140-6736(18)30010-2</mixed-citation><mixed-citation xml:lang="en">Forner A, Reig M, Bruix J. Hepatocellular carcinoma. Lancet. 2018;391(10127):1301-14. https://doi.org/10.1016/S0140-6736(18)30010-2</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Каприн АД, Старинский ВВ, ˌШахзадова АО и др. Состояние онкологической помощи населению России в 2022 году. М.: МНИОИ им. П.А. Герцена о филиал ФГБУ ͨНМИЦ радиологииͩ Минздрава России. 2022.</mixed-citation><mixed-citation xml:lang="en">Каприн АД, Старинский ВВ, ˌахзадова АО и др. Состояние онкологической помощи населению России в 2022 году. М.: МНИОИ им. П.А. Герцена о филиал ФГБУ ͨНМИЦ радиологииͩ Минздрава России. 2022.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Кармазановский ГГ, ˌантаревич М˓, Сташкив ВИ и др. Воспроизводимость текстурных показателей КТ- и МРТ-изображений гепатоцеллюлярного рака. Медицинская визуализация. 2023;27(3):84-93. https://doi.org/10.24835/1607-0763-1372</mixed-citation><mixed-citation xml:lang="en">Kаrmаzаnovsky GG, Shantarevich MY, Stashkiv VI, et al. Reproducibility of CT and MRI texture features of hepatocellular carcinoma. Medical Visualization. 2023;27(3):84-93. (In Russ.) https://doi.org/10.24835/1607-0763-1372</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Marrero JA, Kulik LM, Sirlin CB, et al. Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology. 2018;68(2):723-50. https://doi.org/10.1002/hep.29913</mixed-citation><mixed-citation xml:lang="en">Marrero JA, Kulik LM, Sirlin CB, et al. Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology. 2018;68(2):723-50. https://doi.org/10.1002/hep.29913</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. J Hepatol. 2018;69(1):182-236. https://doi.org/10.1016/j.jhep.2018.03.019</mixed-citation><mixed-citation xml:lang="en">EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. J Hepatol. 2018;69(1):182-236. https://doi.org/10.1016/j.jhep.2018.03.019</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Motosugi U, Bannas P, Sano K, Reeder SB. Hepatobiliary MR contrast agents in hypovascular hepatocellular carcinoma. J Magn Reson Imaging. 2015;41(2):251-65. https://doi.org/10.1002/jmri.24712</mixed-citation><mixed-citation xml:lang="en">Motosugi U, Bannas P, Sano K, Reeder SB. Hepatobiliary MR contrast agents in hypovascular hepatocellular carcinoma. J Magn Reson Imaging. 2015;41(2):251-65. https://doi.org/10.1002/jmri.24712</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Kierans AS, Fowler KJ, Chernyak V. LI-RADS in 2024: recent updates, planned reﬁnements, and future directions. Abdom Radiol (NY). Published online December 13, 2024. https://doi.org/10.1007/s00261-024-04730-w</mixed-citation><mixed-citation xml:lang="en">Kierans AS, Fowler KJ, Chernyak V. LI-RADS in 2024: recent updates, planned reﬁnements, and future directions. Abdom Radiol (NY). Published online December 13, 2024. https://doi.org/10.1007/s00261-024-04730-w</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Кармазановский ГГ, Кондратьев ЕВ, Груздев ИС и др. Современная лучевая диагностика и интеллектуальные персонализированные технологии в гепатопанкреатологии. Вестник Российской академии медицинских наук. 2022;77(4):245-53.</mixed-citation><mixed-citation xml:lang="en">Karmazanovsky GG, Kondratyev EV, Gruzdev IS, et al. Radiation diagnostics and intelligent personalized technologies in hepatopancreatology. Vestnik Rossijskoj akademii nauk 2022;77(4):245-53 (In Russ.) https://doi.org/10.15690/vramn2053</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Mirestean CC, Pagute O, Buzea C, et al. Radiomic Machine Learning and Texture Analysis — New Horizons for Head and Neck Oncology. Maedica (Bucur). 2019;14(2):126-30. https://doi.org/10.26574/maedica.2019.14.2.126</mixed-citation><mixed-citation xml:lang="en">Mirestean CC, Pagute O, Buzea C, et al. Radiomic Machine Learning and Texture Analysis — New Horizons for Head and Neck Oncology. Maedica (Bucur). 2019;14(2):126-30. https://doi.org/10.26574/maedica.2019.14.2.126</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Sagir Kahraman A. Radiomics in Hepatocellular Carcinoma. J Gastrointest Cancer. 2020;51(4):1165-8. https://doi.org/10.1007/s12029-020-00493-x</mixed-citation><mixed-citation xml:lang="en">Sagir Kahraman A. Radiomics in Hepatocellular Carcinoma. J Gastrointest Cancer. 2020;51(4):1165-8. https://doi.org/10.1007/s12029-020-00493-x</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Masokano IB, Liu W, Xie S, Marcellin DFH, Pei Y, Li W. The application of texture quantiﬁcation in hepatocellular carcinoma using CT and MRI: a review of perspectives and challenges. Cancer Imaging. 2020;20(1):67. https://doi.org/10.1186/s40644-020-00341-y</mixed-citation><mixed-citation xml:lang="en">Masokano IB, Liu W, Xie S, Marcellin DFH, Pei Y, Li W. The application of texture quantiﬁcation in hepatocellular carcinoma using CT and MRI: a review of perspectives and challenges. Cancer Imaging. 2020;20(1):67. https://doi.org/10.1186/s40644-020-00341-y</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Молостова ЮВ, Медведева БМ, Кондратьев ЕВ и др. Возможности текстурного анализа и машинного обучения в МРТ-диагностике раннего ГЦР. Онкологический журнал: лучевая диагностика, лучевая терапия. 2024;7(4):68-73. https://doi.org/10.37174/2587-7593-2024-7-4-68-73</mixed-citation><mixed-citation xml:lang="en">Molostova IV, Medvedeva BM, Kondratyev EV et al. The capabilities of machine learning radiomics based models in the MRI diagnosis of early HCC. Journal of Oncology: Diagnostic Radiology and Radiotherapy. 2024;7(4):68-73. (In Russ.). https://doi.org/10.37174/2587-7593-2024-7-4-68-73</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Navin PJ, Venkatesh SK. Hepatocellular Carcinoma: State of the Art Imaging and Recent Advances. J Clin Transl Hepatol. 2019;7(1):72-85. https://doi.org/10.14218/JCTH.2018.00032</mixed-citation><mixed-citation xml:lang="en">Navin PJ, Venkatesh SK. Hepatocellular Carcinoma: State of the Art Imaging and Recent Advances. J Clin Transl Hepatol. 2019;7(1):72-85. https://doi.org/10.14218/JCTH.2018.00032</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Сташкив ВИ, ˌантаревич М˓, Кармазановский ГГ. Предикция степени дифференцировки гепатоцеллюлярного рака по данным текстурного анализа магнитно-резонансных томограмм. Диагностическая и интервенционная радиология, 2023;17(3 Приложение №1):48-57. https://doi.org/10.25512/DIR.2023.17.3(1).07</mixed-citation><mixed-citation xml:lang="en">Stashkiv VI, Shantarevich MY, Kаrmаzаnovsky GG Prediction of the degree of diﬀerentiation of hepatocellular carcinoma using texture analysis of magnetic resonance imaging. Diagnostic interventional Θ Radiology. 2023;17(3№1):48-57. (In Russ.) https://doi.org/10.25512/DIR.2023.17.3(1).07</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Fedorov A, Beichel R, Kalpathy-Cramer J, et al. 3D Slicer as an image computing plaƞorm for the Yuantitative Imaging Network. Magn Reson Imaging. 2012;30(9):1323-41. https://doi.org/10.1016/j.mri.2012.05.001</mixed-citation><mixed-citation xml:lang="en">Fedorov A, Beichel R, Kalpathy-Cramer J, et al. 3D Slicer as an image computing plaƞorm for the Yuantitative Imaging Network. Magn Reson Imaging. 2012;30(9):1323-41. https://doi.org/10.1016/j.mri.2012.05.001</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">van Griethuysen JJM, Fedorov A, Parmar C, et al. Computational Radiomics System to Decode the Radiographic Phenotype. Cancer Res. 2017;77(21):e104-e107. https://doi.org/10.1158/0008-5472.CAN-17-0339</mixed-citation><mixed-citation xml:lang="en">van Griethuysen JJM, Fedorov A, Parmar C, et al. Computational Radiomics System to Decode the Radiographic Phenotype. Cancer Res. 2017;77(21):e104-e107. https://doi.org/10.1158/0008-5472.CAN-17-0339</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
